Full-Dose Anticoagulation Reduces Need for Life Support in COVID-19 Full-Dose Anticoagulation Reduces Need for Life Support in COVID-19

The benefit, along with a trend to lower mortality, was reported in the subgroup of moderately ill patients hospitalized with COVID-19 taking part in three linked trials.Medscape Medical News
Source: Medscape Med Students Headlines - Category: Universities & Medical Training Tags: Cardiology News Source Type: news